I applaud and congratulate leaders like Jeremy Levin (read the interview with him in Fierce Biotech) who have the courage and perseverance to leave comfortable roles and secure jobs in big pharma in order to run risky ventures at small-cap life sciences companies, where the odds are stacked against them but the drive to develop […]
